Skip to main content

BIOS Fund II, LP's Form 4 filing

IN8BIO, Inc. (INAB) · filed May 7, 2025

Accession no.
0001104659-25-045741
Filed
May 7, 2025, 9:48 PM ET
Trade date
May 2, 2025
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 0 non-derivative transactions and 3 derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
BIOS Fund II, LPCIK 000171457610% Owner
BIOS Fund II QP, LPCIK 000171686910% Owner
BIOS Fund II NT, LPCIK 000172885110% Owner
BIOS Incysus Co-Invest I, LPCIK 000174002910% Owner
Fletcher Aaron G.L.CIK 000178949010% Owner
BIOS Advisors GP, LLCCIK 000181384410% Owner
BIOS Capital Management, LPCIK 000181384510% Owner
Bios Clinical Opportunity Fund, LPCIK 000198863910% Owner
Bios Equity COF, LPCIK 000200074710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 2, 2025Common StockPPurchaseAcquired+1,148,482––2,431,763IndirectDuplicate filing
May 2, 2025Common StockJOtherDisposed−574,241––0IndirectDuplicate filing
May 2, 2025Common StockJOtherDisposed−574,241––0IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)